{"gene":"SALL4","run_date":"2026-04-28T20:42:06","timeline":{"discoveries":[{"year":2006,"finding":"Sall4 directly binds the highly conserved distal enhancer region of the Pou5f1 (Oct4) gene and transcriptionally activates Oct4 expression in vivo and in vitro; knockdown of Sall4 in mouse zygotes reduced both Sall4 and Oct4 mRNAs and expanded Cdx2 expression into the inner cell mass, demonstrating that Sall4 is a transcriptional activator of Oct4 required for ES cell pluripotency.","method":"ChIP, luciferase reporter assay, siRNA microinjection into zygotes, in vitro transcription assay","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods (ChIP, reporter assay, in vivo siRNA knockdown) in a single study with replicated findings","pmids":["16980957"],"is_preprint":false},{"year":2006,"finding":"Sall4 physically interacts with Nanog (confirmed by affinity purification/MS, Co-IP, and GST pulldown) and co-occupies Nanog and Sall4 enhancer regions in living ES cells; knockdown of either factor reduces the other's enhancer activity, indicating a positive autoregulatory loop.","method":"Affinity purification coupled to LC-MS/MS, Co-immunoprecipitation, GST pulldown, ChIP","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — reciprocal Co-IP plus GST pulldown plus ChIP, multiple orthogonal methods","pmids":["16840789"],"is_preprint":false},{"year":2006,"finding":"SALL4 promoter contains a consensus TCF/LEF-binding site; LEF1 and TCF4E directly activate the SALL4 promoter, and mutation of the TCF/LEF-binding site reduces promoter activation, demonstrating SALL4 is a direct transcriptional target of canonical Wnt signaling.","method":"Promoter cloning, luciferase reporter assay, site-directed mutagenesis of TCF/LEF binding site","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro reporter assay with mutagenesis, single lab","pmids":["16899215"],"is_preprint":false},{"year":2006,"finding":"In zebrafish, sall4 acts genetically downstream of tbx5 and is required for pectoral fin (forelimb) outgrowth, placing sall4 in the tbx5 pathway during limb development.","method":"Genetic epistasis in zebrafish (morpholino knockdown, overexpression)","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 — clean genetic epistasis in a vertebrate model organism with clear phenotypic readout","pmids":["16501170"],"is_preprint":false},{"year":2008,"finding":"Sall4 is cell-autonomously required for development of epiblast and primitive endoderm from the inner cell mass; Sall4-deficient blastocysts cannot give rise to embryonic or extraembryonic endoderm stem cell lines, whereas trophoblast lineage development is unaffected.","method":"Conditional knockout mice, blastocyst stem cell derivation assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — genetic loss-of-function with specific lineage phenotype readout, replicated in multiple derivation assays","pmids":["17060609"],"is_preprint":false},{"year":2008,"finding":"Genome-wide ChIP-on-chip mapping identified >3,200 Sall4 target genes in mouse ES cells; Sall4 forms a heteromeric protein complex with Oct4 and Nanog (confirmed by co-IP), and decreasing Sall4 reduces expression of Oct4, Sox2, c-Myc, and Klf4.","method":"ChIP-on-chip, Co-immunoprecipitation, RNAi knockdown with expression profiling","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — genome-wide binding map combined with reciprocal Co-IP and functional knockdown, multiple orthogonal methods","pmids":["19060217"],"is_preprint":false},{"year":2008,"finding":"Sall4 regulates distinct gene sets in ES cells versus extraembryonic endoderm (XEN) cells; in ES cells Sall4 forms an autoregulatory network with Oct4, Sox2, and Nanog, while in XEN cells it regulates Gata4, Gata6, Sox7, and Sox17, demonstrating context-dependent transcriptional circuitry.","method":"Genome-wide ChIP-seq/ChIP-chip, siRNA knockdown, gene expression profiling in two distinct stem cell lines","journal":"Cell stem cell","confidence":"High","confidence_rationale":"Tier 2 — genome-wide binding plus functional knockdown in two cell types, strong evidence for distinct regulatory circuits","pmids":["18804426"],"is_preprint":false},{"year":2008,"finding":"Compound Sall1/Sall4 and Sall2/Sall4 mutant mice show significantly increased neural tube defects, and SALL1, SALL2, and SALL4 proteins all co-localize in the nucleus in vitro, suggesting redundant nuclear functions in neurulation.","method":"Compound knockout mouse genetics, nuclear co-localization (immunofluorescence)","journal":"The American journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis with clear neural tube phenotype, supported by localization data","pmids":["18818376"],"is_preprint":false},{"year":2009,"finding":"SALL4 associates with the Mi-2/NuRD (Nucleosome Remodeling and Deacetylase) complex, identified by tandem mass spectrometry from SALL4 immunocomplexes; this complex has HDAC activity. SALL4 binds the promoter regions of PTEN and SALL1 (by ChIP) and represses their transcription through the NuRD complex; in SALL4 transgenic mice, decreased PTEN and SALL1 expression is associated with myeloid leukemia and cystic kidneys, respectively.","method":"Co-immunoprecipitation, tandem mass spectrometry, HDAC activity assay, ChIP, qRT-PCR, transgenic mouse model","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1–2 — MS identification of complex, ChIP confirming binding, functional transgenic readout, multiple orthogonal methods","pmids":["19440552"],"is_preprint":false},{"year":2010,"finding":"Sall4 exists as two isoforms (Sall4a and Sall4b) that form homodimers and heterodimers with each other and each interacts with Nanog; Sall4b (but not Sall4a) preferentially binds highly expressed loci and can alone maintain the pluripotent state, though incompletely, while Sall4a and Sall4b have overlapping but distinct genome-wide binding sites differing in epigenetic marks.","method":"Genome-wide location analysis (ChIP-seq), Co-immunoprecipitation, isoform-specific ES cell rescue experiments","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — genome-wide ChIP plus Co-IP plus isoform-specific rescue, multiple orthogonal methods","pmids":["20837710"],"is_preprint":false},{"year":2010,"finding":"SALL4 and OCT4 form a bidirectional transcriptional feedback loop: SALL4 activates OCT4 expression and OCT4 activates SALL4, while SALL4 also strongly self-represses its own promoter and represses promoters of SALL1 and SALL3, antagonizing OCT4-mediated activation of those genes.","method":"Luciferase reporter assay, ChIP, qRT-PCR, co-transfection","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — reporter assays plus ChIP, single lab","pmids":["20505821"],"is_preprint":false},{"year":2011,"finding":"In differentiating spermatogonial progenitor cells (SPCs), Sall4 physically interacts with Plzf (by Co-IP), sequesters Plzf to non-cognate chromatin domains to de-repress Kit expression (a Plzf target required for differentiation), while Plzf reciprocally antagonizes Sall4 by displacing it from cognate chromatin to induce Sall1 expression.","method":"Co-immunoprecipitation, ChIP, genetic loss-of-function (conditional knockout mice), gene expression analysis","journal":"Cell stem cell","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP plus ChIP plus genetic epistasis, multiple orthogonal methods","pmids":["22385656"],"is_preprint":false},{"year":2012,"finding":"Sall4 directly interacts with Sox2 and Oct-3/4 (confirmed by Co-IP), and co-occupies Oct-Sox composite elements in mouse ES cells (by ChIP); Sall4 overexpression increases reporter activity driven by Oct-Sox elements from Pou5f1 and Nanog promoters.","method":"Co-immunoprecipitation, ChIP, luciferase reporter assay, microarray","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, ChIP, and functional reporter assays, multiple orthogonal methods","pmids":["23269686"],"is_preprint":false},{"year":2012,"finding":"SALL4B is modified by sumoylation at lysine residues 156, 316, 374, and 401; sumoylation is independent of ubiquitination, stabilizes the protein, affects its subcellular localization (SUMO-deficient SALL4B enriched in chromatin fraction), and is required for full transcriptional activation/repression activity and rescue of OCT4 and SOX2 expression.","method":"Site-directed mutagenesis, mass spectrometry, reporter assays, RNAi rescue experiments, subcellular fractionation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis of modification sites combined with functional rescue and subcellular fractionation, multiple methods","pmids":["23012367"],"is_preprint":false},{"year":2013,"finding":"SALL4 binds the promoter of the HOXA9 gene in leukemic cells (by ChIP), interacts with MLL (by Co-IP), and co-occupies the HOXA9 promoter with MLL, leading to enrichment of activating histone marks (H3K4me3); downregulation of HoxA9 in SALL4B leukemic cells reduces replating capacity and delays AML development.","method":"ChIP, Co-immunoprecipitation, shRNA knockdown, bone marrow transplantation mouse model, histone modification analysis","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — ChIP plus Co-IP plus in vivo leukemia model, multiple orthogonal methods","pmids":["24051379"],"is_preprint":false},{"year":2013,"finding":"A peptide that competes with SALL4 for binding to the HDAC (NuRD) complex reverses SALL4-mediated PTEN repression, leading to death of SALL4-expressing leukemic cells in vitro and in vivo in xenograft models; this effect is rescued by a PTEN inhibitor, confirming PTEN as the relevant target.","method":"Peptide competition assay, HDAC activity assay, ChIP, xenograft mouse model, RNAi comparison","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — mechanistic peptide competition validated in vitro and in vivo with rescue experiment","pmids":["23287862"],"is_preprint":false},{"year":2013,"finding":"In hepatocellular carcinoma, blocking SALL4-corepressor (NuRD/HDAC) interactions releases suppression of PTEN, inhibiting tumor formation in xenograft models, establishing that SALL4 drives HCC tumorigenicity at least in part by epigenetic silencing of PTEN.","method":"Loss-of-function studies (RNAi), peptide blockade of SALL4-corepressor interaction, in vivo xenograft assay","journal":"The New England journal of medicine","confidence":"High","confidence_rationale":"Tier 2 — functional loss-of-function plus mechanistic peptide intervention plus in vivo xenograft readout","pmids":["23758232"],"is_preprint":false},{"year":2013,"finding":"An Oct4-Sall4-Nanog network governs pre-implantation mouse embryo development; morpholino-mediated knockdown of each factor followed by transcriptome analysis defined their regulons, including a set of metabolism/transport genes regulated in embryos but not ES cells. DNMT3b, controlled by these factors and miR-290-295, buffers embryos against gene expression noise.","method":"Morpholino knockdown in embryos, single-embryo and single-blastomere transcriptome analysis, genetic epistasis","journal":"Molecular systems biology","confidence":"Medium","confidence_rationale":"Tier 2 — systematic knockdown with transcriptome readout in embryos, single lab","pmids":["23295861"],"is_preprint":false},{"year":2015,"finding":"Sall4 is required for primordial germ cell (PGC) specification; conditional inactivation of Sall4 during PGC specification leads to apoptosis and failure of PGC translocation from mesoderm to endoderm, with derepression of somatic program genes Hoxa1 and Hoxb1 while stem cell program activation is intact. Sall4 binds these somatic gene loci (ChIP) and likely recruits a histone deacetylase repressor complex with Prdm1.","method":"Conditional knockout mice, ChIP, gene expression analysis, cell fate tracking","journal":"Stem cells (Dayton, Ohio)","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with specific PGC phenotype plus ChIP mechanistic data","pmids":["25263278"],"is_preprint":false},{"year":2015,"finding":"Sall4 is required for activating ATM-dependent DNA double-strand break (DSB) responses in mouse ES cells; Sall4 rapidly localizes to DSB sites, interacts with Rad50 (Co-IP), stabilizes the Mre11-Rad50-Nbs1 (MRN) complex for ATM recruitment and activation, and interacts with Baf60a (SWI/SNF complex member) which recruits Sall4 to DSB sites.","method":"Live-cell imaging (localization to DSB sites), Co-immunoprecipitation, siRNA knockdown, ATM activation assays, FRAP","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1–2 — direct visualization of recruitment, reciprocal Co-IP of MRN complex stabilization, functional ATM assay, multiple methods","pmids":["25733712"],"is_preprint":false},{"year":2016,"finding":"Sall4 is an enhancer-binding protein that prevents precocious neural gene expression in ES cells; although a fraction of Sall4 protein physically associates with the NuRD complex, Sall4 neither recruits NuRD to chromatin nor regulates transcription via NuRD — free Sall4 protein regulates transcription independently of NuRD.","method":"Sall4 knockout ES cells, ChIP-seq, proteomics (mass spectrometry), NuRD recruitment assays, gene expression profiling","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1–2 — genome-wide ChIP-seq combined with KO ES cells and proteomic analysis, strong mechanistic dissection","pmids":["27471257"],"is_preprint":false},{"year":2016,"finding":"In undifferentiated spermatogonia, SALL4 and PLZF bind 1295 shared gene targets; SALL4 preferentially binds intronic sites (including DMRT1 differentiation factor motifs) while PLZF binds promoters; knockdown of either factor suppresses mRNA levels of both unique and shared target genes involved in SSC self-renewal and differentiation.","method":"ChIP-seq in mouse THY1+ spermatogonia, motif analysis, shRNA knockdown with expression profiling","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — genome-wide ChIP-seq plus functional knockdown in primary spermatogonia","pmids":["27068105"],"is_preprint":false},{"year":2017,"finding":"SALL4 promotes glycolysis and open chromatin by recruiting ubiquitin E3 ligase CUL4B to heterochromatin protein 1α (HP1α), destabilizing HP1α; loss of SALL4 reduces Glut1 expression and inhibits glycolysis; restoring Glut1 expression rescues impaired DNA damage response in SALL4-deficient cancer cells, establishing a SALL4-HP1α-Glut1 axis.","method":"Co-immunoprecipitation, ubiquitination assay, ChIP, siRNA knockdown, Glut1 rescue experiments","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP and rescue experiments, single lab","pmids":["28759035"],"is_preprint":false},{"year":2017,"finding":"In undifferentiated spermatogonia, SALL4 associates with the NuRD co-repressor and represses tumor suppressor genes Foxl1 and Dusp4; inducible SALL4 knockout leads to long-term functional decline of undifferentiated spermatogonia, and aberrant Foxl1 activation inhibits cell growth and survival while DUSP4 suppresses self-renewal pathways.","method":"Inducible knockout mouse models, Co-immunoprecipitation (NuRD), gene expression analysis, functional spermatogonial assays","journal":"Stem cell reports","confidence":"High","confidence_rationale":"Tier 2 — inducible KO with functional readout plus mechanistic NuRD Co-IP, multiple methods","pmids":["28867346"],"is_preprint":false},{"year":2017,"finding":"SALL4 is required for MLL-AF9-induced leukemic transformation; loss of SALL4 induces apoptosis and G1 arrest in MLL-AF9 cells. SALL4 physically interacts with DOT1L and LSD1/KDM1A (Co-IP) and co-binds MLL-AF9 target gene promoters, affecting H3K79me2/3 and H3K4me3 histone marks to regulate their transcription.","method":"Tamoxifen-inducible Cre-mediated knockout, retroviral transduction/transplantation, ChIP-seq, Co-immunoprecipitation, histone modification analysis","journal":"Journal of hematology & oncology","confidence":"High","confidence_rationale":"Tier 2 — inducible KO in mouse leukemia model plus Co-IP of epigenetic factors plus ChIP-seq","pmids":["28974232"],"is_preprint":false},{"year":2018,"finding":"Crystal structure of SALL4(1–12) N-terminal peptide complexed with RBBp4 (NuRD chaperone subunit) at 2.7 Å resolution was determined; systematic truncation and amino acid substitution defined an FFW peptide with 23 nM affinity that antagonizes SALL4-NuRD interaction; disrupting this interaction converts SALL4 from dual repressor-activator to singular activator mode, upregulating PTEN and inhibiting xenograft tumor growth by 85%.","method":"Crystal structure determination, peptide design with mutagenesis, surface plasmon resonance, transcriptome analysis, xenograft mouse model","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — crystal structure plus mutagenesis plus in vitro affinity measurement plus in vivo validation, single highly rigorous study","pmids":["29976840"],"is_preprint":false},{"year":2018,"finding":"SALL4 binds the promoter of miR-146a-5p and directly controls its expression in HCC exosomes; this SALL4/miR-146a-5p axis drives M2 macrophage polarization and T cell exhaustion.","method":"ChIP assay (SALL4 binding to miR-146a-5p promoter), luciferase reporter, siRNA knockdown, in vivo DEN/CCL4 HCC mouse model","journal":"Oncoimmunology","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP plus reporter assay plus in vivo model, single lab","pmids":["31143524"],"is_preprint":false},{"year":2019,"finding":"SALL4 binds approximately 50% of mitochondrial genes by ChIP-seq and activates their transcription; SALL4-high cancer cells exhibit increased oxidative phosphorylation, oxygen consumption rate, and mitochondrial membrane potential compared to SALL4-knockdown cells, identifying SALL4 as a transcriptional activator of oxidative phosphorylation genes.","method":"ChIP-seq, RNA-seq, oxygen consumption rate measurement, mitochondrial membrane potential assay, xenograft models","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 2 — genome-wide ChIP-seq plus functional metabolic assays plus in vivo validation, strong mechanistic evidence","pmids":["31446059"],"is_preprint":false},{"year":2019,"finding":"Sall4 promotes WNT/β-catenin signaling to maintain neuromesodermal progenitors (NMPs) and regulate their differentiation balance toward neural versus mesodermal fates during body elongation; RNA-seq and ChIP-seq in post-gastrulation embryos confirmed Sall4 directly regulates mesodermal and neural developmental genes.","method":"Conditional knockout (TCre), RNA-seq, ChIP-seq, genetic interaction with WNT pathway","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with defined NMP phenotype plus genome-wide binding data","pmids":["31235634"],"is_preprint":false},{"year":2019,"finding":"SALL4 directly binds and transcriptionally activates CTNNB1 (β-catenin) promoter (confirmed by ChIP and dual-luciferase assay), activating Wnt/β-catenin signaling and increasing c-Myc and cyclin D1 in cervical cancer cells.","method":"ChIP assay, dual-luciferase reporter assay, Western blot, TOP/FOP-Flash Wnt reporter","journal":"Cancer science","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP plus reporter assay confirming direct promoter binding, single lab","pmids":["31336010"],"is_preprint":false},{"year":2020,"finding":"Thalidomide and IMiD analogs (lenalidomide, pomalidomide) induce SALL4 degradation through the CRBN-containing CRL4 E3 ubiquitin ligase complex; CRBN V388I or SALL4 G416A mutations block IMiD-induced SALL4 degradation and protect hiPSC mesendoderm differentiation from thalidomide, establishing CRBN-dependent SALL4 degradation as the mechanism of teratogenicity.","method":"hiPSC differentiation assays, CRBN and SALL4 point-mutant knock-in cells, proteasome inhibitor experiments, flow cytometry","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1–2 — mutagenesis of both CRBN and SALL4 with functional rescue, mechanistic demonstration of ubiquitin-mediated degradation","pmids":["32071327"],"is_preprint":false},{"year":2021,"finding":"SALL4 contains an AT-rich DNA-binding zinc-finger cluster that is essential for genome occupancy; mutation of this AT-binding domain drastically reduces SALL4 chromatin binding, causes premature upregulation of AT-rich neural genes proportional to AT content, and mimics Sall4 null defects including precocious ESC differentiation and embryonic lethality in mice.","method":"Zinc-finger mutagenesis, ChIP-seq, RNA-seq, mouse knock-in genetics","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 — structure-function mutagenesis combined with genome-wide ChIP-seq and in vivo mouse model, highly rigorous single study","pmids":["33406384"],"is_preprint":false},{"year":2021,"finding":"SALL4 negatively regulates melanoma cell invasiveness through interaction with HDAC2; SALL4 and HDAC2 co-bind a set of invasiveness genes, and SALL4 loss promotes an invasive phenotype; HDAC inhibition phenocopies SALL4 loss, while inhibition of histone acetylation partially reverts the invasiveness induced by SALL4 knockdown.","method":"Co-immunoprecipitation (SALL4-HDAC2), ChIP, transcriptional profiling, mouse melanoma model (Tyr::NrasQ61K;Cdkn2a-/-), in vitro invasion assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — Co-IP plus ChIP plus in vivo melanoma model, multiple orthogonal methods","pmids":["34417458"],"is_preprint":false},{"year":2023,"finding":"The NuRD complex participates in chromatin closing during early somatic reprogramming; Sall4 uniquely recruits endogenous NuRD components among the reprogramming factors, and disrupting the N-terminal NuRD-interacting motif of Sall4 (by mutation or deletion) abolishes reprogramming ability; grafting this motif onto Jdp2 partially rescues reprogramming, demonstrating that Sall4-NuRD interaction is functionally essential for closing open chromatin.","method":"Co-immunoprecipitation, N-terminal motif mutagenesis/deletion, ATAC-seq (chromatin accessibility dynamics), iPSC reprogramming efficiency assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1–2 — mutagenesis plus domain-swap rescue plus genome-wide ATAC-seq, multiple rigorous methods","pmids":["37208322"],"is_preprint":false},{"year":2011,"finding":"SALL4 binds the promoter of ABCA3 (confirmed by ChIP and EMSA) and directly activates ABCA3 expression, while regulating ABCG2 indirectly; SALL4 expression is enriched in drug-resistant side population (SP) cancer cells and its knockdown reduces SP cell frequency, linking SALL4 to drug resistance via ABC transporter regulation.","method":"ChIP, EMSA, qRT-PCR, siRNA knockdown, SP cell sorting","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP plus EMSA confirming direct promoter binding, functional knockdown, single lab","pmids":["21526180"],"is_preprint":false},{"year":2015,"finding":"SALL4 directly binds the c-Myc promoter (confirmed by ChIP) and upregulates c-Myc expression; c-Myc depletion abolishes SALL4-induced EMT (downregulation of E-cadherin, upregulation of N-cadherin) and drug resistance (via ABCB1) in endometrial cancer cells.","method":"ChIP assay, siRNA knockdown, Western blot, invasion assays","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP plus functional rescue experiment, single lab","pmids":["26407074"],"is_preprint":false},{"year":2016,"finding":"SALL4 directly binds the CD44 promoter (confirmed by ChIP and luciferase assay) and transcriptionally activates CD44; CD44 overexpression rescues SALL4 knockdown-mediated inhibition of gastric cancer cell proliferation and invasion, establishing CD44 as a direct SALL4 target.","method":"ChIP, luciferase reporter assay, shRNA knockdown with rescue overexpression, in vivo xenograft","journal":"Oncogenesis","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP plus reporter plus rescue experiment, single lab","pmids":["27819668"],"is_preprint":false},{"year":2018,"finding":"SALL4 directly activates TGF-β1 transcription by binding its promoter (confirmed by ChIP and luciferase assay); TGF-β1 knockdown reverses SALL4-mediated promotion of gastric cancer motility and invasion, placing SALL4 upstream of TGF-β/SMAD-driven EMT.","method":"ChIP, luciferase reporter assay, microarray for target identification, invasion assays, peritoneal metastasis model","journal":"Cancer management and research","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP plus reporter assay plus functional rescue, single lab","pmids":["30349378"],"is_preprint":false}],"current_model":"SALL4 is a zinc-finger transcription factor that maintains pluripotency and stem cell identity by directly activating key target genes (Oct4/Pou5f1, Nanog, HOXA9, CD44, TGF-β1, CTNNB1, oxidative phosphorylation genes) through binding to their enhancers/promoters, and repressing tumor suppressors (PTEN, SALL1, Foxl1, Dusp4) and neural differentiation genes through recruitment of the NuRD/HDAC co-repressor complex via its N-terminal motif; it physically interacts with Oct4, Sox2, Nanog, MLL, PLZF, Rad50, HDAC2, and CUL4B, responds to Wnt/TCF-LEF signaling (which directly activates its promoter), is post-translationally regulated by sumoylation (stabilizing the protein and modulating its transcriptional activity) and by CRBN-dependent ubiquitin-mediated proteasomal degradation induced by thalidomide/IMiDs, and its AT-rich DNA-binding zinc-finger cluster is essential for chromatin occupancy and prevention of precocious neural differentiation."},"narrative":{"teleology":[{"year":2006,"claim":"Establishing SALL4 as a direct transcriptional activator of the core pluripotency gene Oct4 answered how the inner cell mass maintains Oct4 expression and resolved that SALL4 occupies the Pou5f1 distal enhancer to prevent trophoblast fate.","evidence":"ChIP, luciferase reporter, siRNA knockdown in mouse zygotes","pmids":["16980957"],"confidence":"High","gaps":["Whether SALL4 activates Oct4 independently or requires cofactors was unresolved","Mechanism of transcriptional activation (chromatin remodeling vs. polymerase recruitment) unknown"]},{"year":2006,"claim":"Demonstrating that SALL4 physically interacts with Nanog and that the two factors co-occupy each other's enhancers revealed a positive autoregulatory loop that stabilizes the pluripotency network, while identification of SALL4 as a Wnt/TCF-LEF target gene placed it downstream of a major developmental signaling pathway.","evidence":"Affinity purification/MS, Co-IP, GST pulldown, ChIP (SALL4-Nanog); luciferase reporter with TCF/LEF site mutagenesis (Wnt regulation)","pmids":["16840789","16899215"],"confidence":"High","gaps":["Whether Wnt-mediated SALL4 induction is the primary mechanism activating SALL4 in vivo remained untested","Stoichiometry of the SALL4-Nanog complex unknown"]},{"year":2008,"claim":"Genome-wide binding maps and genetic loss-of-function showed SALL4 occupies thousands of targets and is essential for epiblast and primitive endoderm but not trophoblast, establishing context-dependent regulatory circuits distinct between ES and extraembryonic endoderm cells.","evidence":"ChIP-on-chip/ChIP-seq in ES and XEN cells, conditional knockout mice, stem cell derivation assays","pmids":["17060609","19060217","18804426"],"confidence":"High","gaps":["How SALL4 switches between activating and repressive modes in different lineages was unknown","Whether SALL4 isoforms contribute to lineage-specific programs was unresolved"]},{"year":2009,"claim":"Identification of SALL4 as a recruiter of the NuRD/HDAC co-repressor complex that silences PTEN and SALL1 explained how SALL4 functions as a transcriptional repressor and linked this mechanism to myeloid leukemia and cystic kidney phenotypes.","evidence":"Co-IP/tandem mass spectrometry of SALL4 immunocomplexes, ChIP on PTEN and SALL1 promoters, HDAC activity assay, transgenic mouse model","pmids":["19440552"],"confidence":"High","gaps":["Whether NuRD is required for all SALL4-mediated repression or only a subset of targets was unknown","Structural basis of the SALL4-NuRD interaction was unresolved"]},{"year":2010,"claim":"Discovery that Sall4a and Sall4b isoforms form homo- and heterodimers, occupy distinct but overlapping genomic sites, and differ in capacity to maintain pluripotency (Sall4b sufficient, Sall4a insufficient alone) revealed isoform-specific division of labor.","evidence":"Isoform-specific ChIP-seq, Co-IP, ES cell rescue experiments","pmids":["20837710"],"confidence":"High","gaps":["Structural basis for differential DNA binding of isoforms unknown","How isoform ratio is regulated during differentiation was unresolved"]},{"year":2011,"claim":"Showing that SALL4 and PLZF physically interact and mutually redistribute each other on chromatin in spermatogonia established a reciprocal chromatin-sequestration mechanism controlling the self-renewal-to-differentiation switch in male germline stem cells.","evidence":"Co-IP, ChIP, conditional knockout mice, gene expression analysis in spermatogonial progenitor cells","pmids":["22385656"],"confidence":"High","gaps":["Whether this sequestration mechanism operates in other stem cell compartments was unknown","Genome-wide redistribution of SALL4 by PLZF was not mapped"]},{"year":2012,"claim":"Identification of sumoylation sites on SALL4B and demonstration that sumoylation stabilizes the protein, modulates its chromatin association, and is required for full transcriptional activity established the first post-translational regulatory mechanism for SALL4.","evidence":"Site-directed mutagenesis of four lysines, mass spectrometry, subcellular fractionation, reporter assays, RNAi rescue in ES cells","pmids":["23012367"],"confidence":"High","gaps":["Identity of the SUMO E3 ligase for SALL4 was unknown","Whether sumoylation is regulated during differentiation was untested"]},{"year":2013,"claim":"Demonstrating that SALL4 cooperates with MLL at the HOXA9 promoter via physical interaction and co-occupancy with activating H3K4me3 marks explained how SALL4 drives leukemogenic gene expression programs, while peptide disruption of the SALL4-NuRD interface validated PTEN de-repression as a therapeutic vulnerability in SALL4-expressing cancers.","evidence":"ChIP, Co-IP, bone marrow transplantation leukemia model (SALL4-MLL); peptide competition, xenograft models, PTEN inhibitor rescue (SALL4-NuRD-PTEN)","pmids":["24051379","23287862","23758232"],"confidence":"High","gaps":["Whether SALL4 cooperates with MLL independent of NuRD was unresolved","In vivo pharmacokinetics of NuRD-disrupting peptides were not established"]},{"year":2015,"claim":"Revealing that SALL4 rapidly localizes to DNA double-strand breaks, stabilizes the MRN complex through direct Rad50 interaction, and is required for ATM activation uncovered an unexpected non-transcriptional role for SALL4 in the DNA damage response.","evidence":"Live-cell imaging, FRAP, Co-IP with Rad50 and Baf60a, ATM phosphorylation assays in ES cells","pmids":["25733712"],"confidence":"High","gaps":["Whether SALL4's DSB role is specific to ES cells or general was unknown","Structural basis of SALL4-Rad50 interaction unresolved","Whether SALL4 DNA damage function is independent of its transcriptional role was unclear"]},{"year":2016,"claim":"Genome-wide analysis in Sall4 knockout ES cells showed SALL4 acts primarily at enhancers to prevent precocious neural gene activation, and critically, that although SALL4 physically associates with NuRD, it does not recruit NuRD to chromatin — challenging the prevailing model of SALL4 as a NuRD-dependent repressor.","evidence":"ChIP-seq and proteomics in Sall4 KO ES cells, NuRD recruitment assays","pmids":["27471257"],"confidence":"High","gaps":["How to reconcile this with functional NuRD-dependence shown in cancer and spermatogonia was unclear","Identity of the actual repressive mechanism at neural enhancers was unknown"]},{"year":2018,"claim":"Solving the crystal structure of the SALL4 N-terminal peptide bound to RBBp4 and engineering a high-affinity competitive peptide (23 nM) that converts SALL4 from repressor to activator provided the structural basis for the NuRD interaction and a pharmacological strategy to de-repress PTEN in tumors.","evidence":"X-ray crystallography at 2.7 Å, surface plasmon resonance, systematic peptide truncation/mutagenesis, xenograft tumor model","pmids":["29976840"],"confidence":"High","gaps":["Whether small molecules can mimic the peptide antagonist was unknown","Whether other NuRD-binding transcription factors share this structural interface was untested"]},{"year":2020,"claim":"Demonstrating that thalidomide/IMiDs induce SALL4 degradation via the CRBN-CRL4 E3 ubiquitin ligase, and that point mutations in either CRBN or SALL4 block degradation and rescue mesendoderm differentiation, established CRBN-dependent SALL4 destruction as the molecular mechanism of thalidomide teratogenicity.","evidence":"CRBN V388I and SALL4 G416A knock-in hiPSCs, proteasome inhibitor treatment, mesendoderm differentiation assays","pmids":["32071327"],"confidence":"High","gaps":["Structural basis of the SALL4-thalidomide-CRBN ternary complex was not determined","Whether SALL4 degradation alone fully accounts for all limb teratogenicity phenotypes was uncertain"]},{"year":2021,"claim":"Structure-function analysis of the SALL4 AT-rich DNA-binding zinc-finger cluster showed it is essential for genome-wide chromatin occupancy and that its loss causes premature derepression of AT-rich neural genes, establishing the DNA-binding mechanism underlying SALL4's anti-differentiation function.","evidence":"Zinc-finger mutagenesis, ChIP-seq, RNA-seq, mouse knock-in genetics","pmids":["33406384"],"confidence":"High","gaps":["Whether AT-richness fully explains target selectivity or additional sequence features contribute was unknown","How AT-binding cooperates with cofactor interactions was unresolved"]},{"year":2023,"claim":"Showing that SALL4's N-terminal NuRD-interacting motif is essential for chromatin closing during somatic reprogramming, and that grafting this motif onto a non-reprogramming factor partially rescues iPSC generation, reconciled the ES cell finding (NuRD-independent) with a functional NuRD requirement in the reprogramming context.","evidence":"N-terminal motif mutagenesis/deletion, domain-swap onto Jdp2, ATAC-seq, iPSC reprogramming assays","pmids":["37208322"],"confidence":"High","gaps":["Whether NuRD recruitment is required transiently or throughout reprogramming was unclear","Which specific NuRD subunits are essential for this chromatin-closing function was not defined"]},{"year":null,"claim":"Key unresolved questions include: how SALL4's NuRD-dependent and NuRD-independent transcriptional activities are partitioned across cell types; the structural basis of the SALL4-CRBN-thalidomide ternary complex; and whether SALL4's DNA damage response function is mechanistically separable from its transcriptional role.","evidence":"","pmids":[],"confidence":"Low","gaps":["Full structural characterization of SALL4-CRBN-IMiD ternary complex lacking","Context-dependent rules governing NuRD-dependent vs. NuRD-independent repression undefined","Whether SALL4 DSB function operates outside stem cells not tested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,5,6,9,20,31]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,5,6,8,10,14,20,27,31]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[11,22]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[7,13,20,31]},{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[19,31]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[3,4,18,28]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[8,20,25,33]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[19]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[14,24,16]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,28,29,30]}],"complexes":["NuRD/Mi-2 complex","Oct4-Sox2-Nanog-Sall4 pluripotency complex"],"partners":["POU5F1","NANOG","SOX2","RBBP4","PLZF","RAD50","MLL","HDAC2"],"other_free_text":[]},"mechanistic_narrative":"SALL4 is a zinc-finger transcription factor that serves as a master regulator of pluripotency, stem cell self-renewal, and lineage specification across embryonic, germline, and hematopoietic compartments. It maintains the pluripotent state by physically interacting with Oct4, Sox2, and Nanog to co-occupy and activate enhancers of core pluripotency genes (Pou5f1, Nanog), while repressing differentiation and tumor-suppressor genes (PTEN, SALL1, Foxl1) through recruitment of the NuRD/HDAC co-repressor complex via a structurally defined N-terminal RBBp4-binding motif; this dual activator–repressor function is essential for somatic reprogramming and prevention of precocious neural differentiation [PMID:16980957, PMID:19440552, PMID:27471257, PMID:37208322, PMID:29976840]. Its AT-rich DNA-binding zinc-finger cluster is required for genome-wide chromatin occupancy, and mutation of this domain phenocopies Sall4 nulls including embryonic lethality [PMID:33406384]. SALL4 is post-translationally regulated by sumoylation, which stabilizes the protein and modulates transcriptional output, and by CRBN-dependent ubiquitin-mediated proteasomal degradation induced by thalidomide/IMiDs — establishing SALL4 degradation as the mechanism underlying thalidomide teratogenicity [PMID:23012367, PMID:32071327]."},"prefetch_data":{"uniprot":{"accession":"Q9UJQ4","full_name":"Sal-like protein 4","aliases":["Zinc finger protein 797","Zinc finger protein SALL4"],"length_aa":1053,"mass_kda":112.2,"function":"Transcription factor with a key role in the maintenance and self-renewal of embryonic and hematopoietic stem cells","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9UJQ4/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SALL4","classification":"Not Classified","n_dependent_lines":9,"n_total_lines":1208,"dependency_fraction":0.0074503311258278145},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SALL4","total_profiled":1310},"omim":[{"mim_id":"618365","title":"ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 10; ZSCAN10","url":"https://www.omim.org/entry/618365"},{"mim_id":"616837","title":"HUMAN PLURIPOTENCY-ASSOCIATED TRANSCRIPT 5, NONCODING","url":"https://www.omim.org/entry/616837"},{"mim_id":"616374","title":"BEN DOMAIN-CONTAINING PROTEIN 3; BEND3","url":"https://www.omim.org/entry/616374"},{"mim_id":"607343","title":"SAL-LIKE 4; SALL4","url":"https://www.omim.org/entry/607343"},{"mim_id":"607323","title":"DUANE-RADIAL RAY SYNDROME; DRRS","url":"https://www.omim.org/entry/607323"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"testis","ntpm":3.8},{"tissue":"thyroid gland","ntpm":5.6}],"url":"https://www.proteinatlas.org/search/SALL4"},"hgnc":{"alias_symbol":["dJ1112F19.1","ZNF797"],"prev_symbol":[]},"alphafold":{"accession":"Q9UJQ4","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UJQ4","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UJQ4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UJQ4-F1-predicted_aligned_error_v6.png","plddt_mean":51.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SALL4","jax_strain_url":"https://www.jax.org/strain/search?query=SALL4"},"sequence":{"accession":"Q9UJQ4","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UJQ4.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UJQ4/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UJQ4"}},"corpus_meta":[{"pmid":"16980957","id":"PMC_16980957","title":"Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1.","date":"2006","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16980957","citation_count":459,"is_preprint":false},{"pmid":"16840789","id":"PMC_16840789","title":"Sall4 interacts with Nanog and co-occupies Nanog genomic sites in embryonic stem cells.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16840789","citation_count":234,"is_preprint":false},{"pmid":"23758232","id":"PMC_23758232","title":"Oncofetal gene SALL4 in aggressive hepatocellular carcinoma.","date":"2013","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23758232","citation_count":205,"is_preprint":false},{"pmid":"18804426","id":"PMC_18804426","title":"Sall4 regulates distinct transcription circuitries in different blastocyst-derived stem cell lineages.","date":"2008","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/18804426","citation_count":189,"is_preprint":false},{"pmid":"19060217","id":"PMC_19060217","title":"Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19060217","citation_count":173,"is_preprint":false},{"pmid":"19390421","id":"PMC_19390421","title":"SALL4 is a novel diagnostic marker for testicular germ cell tumors.","date":"2009","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/19390421","citation_count":170,"is_preprint":false},{"pmid":"23175232","id":"PMC_23175232","title":"Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers.","date":"2013","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/23175232","citation_count":160,"is_preprint":false},{"pmid":"17060609","id":"PMC_17060609","title":"Murine inner cell mass-derived lineages depend on Sall4 function.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17060609","citation_count":155,"is_preprint":false},{"pmid":"31143524","id":"PMC_31143524","title":"SALL4-mediated upregulation of exosomal miR-146a-5p drives T-cell exhaustion by M2 tumor-associated macrophages in HCC.","date":"2019","source":"Oncoimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/31143524","citation_count":154,"is_preprint":false},{"pmid":"20837710","id":"PMC_20837710","title":"Differential roles of Sall4 isoforms in embryonic stem cell pluripotency.","date":"2010","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20837710","citation_count":145,"is_preprint":false},{"pmid":"22385656","id":"PMC_22385656","title":"Functional antagonism between Sall4 and Plzf defines germline progenitors.","date":"2012","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/22385656","citation_count":143,"is_preprint":false},{"pmid":"19440552","id":"PMC_19440552","title":"Stem cell factor SALL4 represses the transcriptions of PTEN and SALL1 through an epigenetic repressor complex.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19440552","citation_count":143,"is_preprint":false},{"pmid":"19365862","id":"PMC_19365862","title":"SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors.","date":"2009","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/19365862","citation_count":129,"is_preprint":false},{"pmid":"20505821","id":"PMC_20505821","title":"A novel SALL4/OCT4 transcriptional feedback network for pluripotency of embryonic stem cells.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20505821","citation_count":128,"is_preprint":false},{"pmid":"19476507","id":"PMC_19476507","title":"Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts.","date":"2009","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/19476507","citation_count":126,"is_preprint":false},{"pmid":"18487508","id":"PMC_18487508","title":"SALL4 is a key regulator of survival and apoptosis in human leukemic cells.","date":"2008","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/18487508","citation_count":125,"is_preprint":false},{"pmid":"12843316","id":"PMC_12843316","title":"Mutations at the SALL4 locus on chromosome 20 result in a range of clinically overlapping phenotypes, including Okihiro syndrome, Holt-Oram syndrome, acro-renal-ocular syndrome, and patients previously reported to represent thalidomide embryopathy.","date":"2003","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12843316","citation_count":125,"is_preprint":false},{"pmid":"25919570","id":"PMC_25919570","title":"MicroRNA-33b Inhibits Breast Cancer Metastasis by Targeting HMGA2, SALL4 and Twist1.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/25919570","citation_count":124,"is_preprint":false},{"pmid":"24012616","id":"PMC_24012616","title":"The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma.","date":"2013","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/24012616","citation_count":121,"is_preprint":false},{"pmid":"24276240","id":"PMC_24276240","title":"SALL4, a novel marker for human gastric carcinogenesis and metastasis.","date":"2013","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/24276240","citation_count":104,"is_preprint":false},{"pmid":"26892498","id":"PMC_26892498","title":"SALL4, the missing link between stem cells, development and cancer.","date":"2016","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/26892498","citation_count":97,"is_preprint":false},{"pmid":"29593314","id":"PMC_29593314","title":"Oncofetal gene SALL4 reactivation by hepatitis B virus counteracts miR-200c in PD-L1-induced T cell exhaustion.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29593314","citation_count":89,"is_preprint":false},{"pmid":"23326552","id":"PMC_23326552","title":"SALL4 expression in gonocytes and spermatogonial clones of postnatal mouse testes.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23326552","citation_count":87,"is_preprint":false},{"pmid":"27068105","id":"PMC_27068105","title":"The regulatory repertoire of PLZF and SALL4 in undifferentiated spermatogonia.","date":"2016","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/27068105","citation_count":82,"is_preprint":false},{"pmid":"25444934","id":"PMC_25444934","title":"SALL4: an emerging cancer biomarker and target.","date":"2014","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/25444934","citation_count":80,"is_preprint":false},{"pmid":"27329034","id":"PMC_27329034","title":"Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma.","date":"2016","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/27329034","citation_count":76,"is_preprint":false},{"pmid":"30349378","id":"PMC_30349378","title":"SALL4 activates TGF-β/SMAD signaling pathway to induce EMT and promote gastric cancer metastasis.","date":"2018","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/30349378","citation_count":74,"is_preprint":false},{"pmid":"21274508","id":"PMC_21274508","title":"SALL4 is essential for cancer cell proliferation and is overexpressed at early clinical stages in breast cancer.","date":"2011","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/21274508","citation_count":74,"is_preprint":false},{"pmid":"23363002","id":"PMC_23363002","title":"Role of SALL4 in the progression and metastasis of colorectal cancer.","date":"2013","source":"Journal of biomedical science","url":"https://pubmed.ncbi.nlm.nih.gov/23363002","citation_count":73,"is_preprint":false},{"pmid":"21725617","id":"PMC_21725617","title":"Overexpression of SALL4 in lung cancer and its importance in cell proliferation.","date":"2011","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/21725617","citation_count":71,"is_preprint":false},{"pmid":"16899215","id":"PMC_16899215","title":"SALL4 is directly activated by TCF/LEF in the canonical Wnt signaling pathway.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16899215","citation_count":66,"is_preprint":false},{"pmid":"23811124","id":"PMC_23811124","title":"Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4.","date":"2013","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/23811124","citation_count":62,"is_preprint":false},{"pmid":"17216607","id":"PMC_17216607","title":"A Sall4 mutant mouse model useful for studying the role of Sall4 in early embryonic development and organogenesis.","date":"2007","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/17216607","citation_count":62,"is_preprint":false},{"pmid":"27471257","id":"PMC_27471257","title":"Sall4 controls differentiation of pluripotent cells independently of the Nucleosome Remodelling and Deacetylation (NuRD) complex.","date":"2016","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/27471257","citation_count":60,"is_preprint":false},{"pmid":"19820689","id":"PMC_19820689","title":"Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system: a study of 77 cases.","date":"2009","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/19820689","citation_count":59,"is_preprint":false},{"pmid":"23287862","id":"PMC_23287862","title":"Targeting transcription factor SALL4 in acute myeloid leukemia by interrupting its interaction with an epigenetic complex.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/23287862","citation_count":58,"is_preprint":false},{"pmid":"21526180","id":"PMC_21526180","title":"SALL4, a stem cell factor, affects the side population by regulation of the ATP-binding cassette drug transport genes.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21526180","citation_count":57,"is_preprint":false},{"pmid":"23295861","id":"PMC_23295861","title":"An Oct4-Sall4-Nanog network controls developmental progression in the pre-implantation mouse embryo.","date":"2013","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/23295861","citation_count":56,"is_preprint":false},{"pmid":"28867346","id":"PMC_28867346","title":"Germline Stem Cell Activity Is Sustained by SALL4-Dependent Silencing of Distinct Tumor Suppressor Genes.","date":"2017","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28867346","citation_count":55,"is_preprint":false},{"pmid":"26407074","id":"PMC_26407074","title":"SALL4 as an Epithelial-Mesenchymal Transition and Drug Resistance Inducer through the Regulation of c-Myc in Endometrial Cancer.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26407074","citation_count":55,"is_preprint":false},{"pmid":"18818376","id":"PMC_18818376","title":"Sall1, sall2, and sall4 are required for neural tube closure in mice.","date":"2008","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/18818376","citation_count":54,"is_preprint":false},{"pmid":"27677076","id":"PMC_27677076","title":"MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27677076","citation_count":53,"is_preprint":false},{"pmid":"31446059","id":"PMC_31446059","title":"New High-Throughput Screening Identifies Compounds That Reduce Viability Specifically in Liver Cancer Cells That Express High Levels of SALL4 by Inhibiting Oxidative Phosphorylation.","date":"2019","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/31446059","citation_count":53,"is_preprint":false},{"pmid":"16501170","id":"PMC_16501170","title":"sall4 acts downstream of tbx5 and is required for pectoral fin outgrowth.","date":"2006","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16501170","citation_count":52,"is_preprint":false},{"pmid":"21943195","id":"PMC_21943195","title":"Enhanced self-renewal of hematopoietic stem/progenitor cells mediated by the stem cell gene Sall4.","date":"2011","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/21943195","citation_count":51,"is_preprint":false},{"pmid":"29976840","id":"PMC_29976840","title":"Targeting cancer addiction for SALL4 by shifting its transcriptome with a pharmacologic peptide.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29976840","citation_count":49,"is_preprint":false},{"pmid":"31336010","id":"PMC_31336010","title":"SALL4 promotes the tumorigenicity of cervical cancer cells through activation of the Wnt/β-catenin pathway via CTNNB1.","date":"2019","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/31336010","citation_count":47,"is_preprint":false},{"pmid":"26238082","id":"PMC_26238082","title":"miR-219-5p plays a tumor suppressive role in colon cancer by targeting oncogene Sall4.","date":"2015","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/26238082","citation_count":47,"is_preprint":false},{"pmid":"27068524","id":"PMC_27068524","title":"SALL4 expression in gestational trophoblastic tumors: a useful tool to distinguish choriocarcinoma from placental site trophoblastic tumor and epithelioid trophoblastic tumor.","date":"2016","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/27068524","citation_count":45,"is_preprint":false},{"pmid":"34455417","id":"PMC_34455417","title":"Exosomal microRNA-15a from mesenchymal stem cells impedes hepatocellular carcinoma progression via downregulation of SALL4.","date":"2021","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/34455417","citation_count":45,"is_preprint":false},{"pmid":"31216469","id":"PMC_31216469","title":"Induction of Pluripotent Stem Cells from Mouse Embryonic Fibroblasts by Jdp2-Jhdm1b-Mkk6-Glis1-Nanog-Essrb-Sall4.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31216469","citation_count":43,"is_preprint":false},{"pmid":"25733712","id":"PMC_25733712","title":"Stemness factor Sall4 is required for DNA damage response in embryonic stem cells.","date":"2015","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/25733712","citation_count":43,"is_preprint":false},{"pmid":"25479928","id":"PMC_25479928","title":"ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.","date":"2014","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25479928","citation_count":43,"is_preprint":false},{"pmid":"21305648","id":"PMC_21305648","title":"Dedifferentiation and the role of sall4 in reprogramming and patterning during amphibian limb regeneration.","date":"2011","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/21305648","citation_count":42,"is_preprint":false},{"pmid":"30423818","id":"PMC_30423818","title":"miR-103/miR-195/miR-15b Regulate SALL4 and Inhibit Proliferation and Migration in Glioma.","date":"2018","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/30423818","citation_count":42,"is_preprint":false},{"pmid":"24051379","id":"PMC_24051379","title":"A SALL4/MLL/HOXA9 pathway in murine and human myeloid leukemogenesis.","date":"2013","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/24051379","citation_count":41,"is_preprint":false},{"pmid":"35216168","id":"PMC_35216168","title":"SALL4 Oncogenic Function in Cancers: Mechanisms and Therapeutic Relevance.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35216168","citation_count":40,"is_preprint":false},{"pmid":"23269686","id":"PMC_23269686","title":"Stemness-related factor Sall4 interacts with transcription factors Oct-3/4 and Sox2 and occupies Oct-Sox elements in mouse embryonic stem cells.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23269686","citation_count":39,"is_preprint":false},{"pmid":"30907073","id":"PMC_30907073","title":"SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway.","date":"2019","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30907073","citation_count":37,"is_preprint":false},{"pmid":"27819668","id":"PMC_27819668","title":"SALL4 promotes gastric cancer progression through activating CD44 expression.","date":"2016","source":"Oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/27819668","citation_count":37,"is_preprint":false},{"pmid":"29308206","id":"PMC_29308206","title":"SALL4 as a transcriptional and epigenetic regulator in normal and leukemic hematopoiesis.","date":"2018","source":"Biomarker research","url":"https://pubmed.ncbi.nlm.nih.gov/29308206","citation_count":36,"is_preprint":false},{"pmid":"33406384","id":"PMC_33406384","title":"SALL4 controls cell fate in response to DNA base composition.","date":"2021","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/33406384","citation_count":33,"is_preprint":false},{"pmid":"28959334","id":"PMC_28959334","title":"Anticancer Properties of Chrysin on Colon Cancer Cells, In vitro and In vivo with Modulation of Caspase-3, -9, Bax and Sall4.","date":"2016","source":"Iranian journal of biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/28959334","citation_count":33,"is_preprint":false},{"pmid":"28759035","id":"PMC_28759035","title":"SALL4 promotes glycolysis and chromatin remodeling via modulating HP1α-Glut1 pathway.","date":"2017","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/28759035","citation_count":32,"is_preprint":false},{"pmid":"32320856","id":"PMC_32320856","title":"miR-296-5p suppresses stem cell potency of hepatocellular carcinoma cells via regulating Brg1/Sall4 axis.","date":"2020","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/32320856","citation_count":32,"is_preprint":false},{"pmid":"23432194","id":"PMC_23432194","title":"Tyrosinekinase inhibition facilitates cooperation of transcription factor SALL4 and ABC transporter A3 towards intrinsic CML cell drug resistance.","date":"2013","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/23432194","citation_count":32,"is_preprint":false},{"pmid":"25646965","id":"PMC_25646965","title":"Significance of SALL4 as a drug‑resistant factor in lung cancer.","date":"2015","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/25646965","citation_count":31,"is_preprint":false},{"pmid":"28974232","id":"PMC_28974232","title":"The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis.","date":"2017","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/28974232","citation_count":31,"is_preprint":false},{"pmid":"29691367","id":"PMC_29691367","title":"Upregulation of SALL4 by EGFR activation regulates the stemness of CD44-positive lung cancer.","date":"2018","source":"Oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/29691367","citation_count":31,"is_preprint":false},{"pmid":"31235634","id":"PMC_31235634","title":"Sall4 regulates neuromesodermal progenitors and their descendants during body elongation in mouse embryos.","date":"2019","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31235634","citation_count":30,"is_preprint":false},{"pmid":"25263278","id":"PMC_25263278","title":"Sall4 is essential for mouse primordial germ cell specification by suppressing somatic cell program genes.","date":"2015","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/25263278","citation_count":30,"is_preprint":false},{"pmid":"23012367","id":"PMC_23012367","title":"Sumoylation is important for stability, subcellular localization, and transcriptional activity of SALL4, an essential stem cell transcription factor.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23012367","citation_count":30,"is_preprint":false},{"pmid":"24286030","id":"PMC_24286030","title":"A Cdx4-Sall4 regulatory module controls the transition from mesoderm formation to embryonic hematopoiesis.","date":"2013","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/24286030","citation_count":29,"is_preprint":false},{"pmid":"37208322","id":"PMC_37208322","title":"The NuRD complex cooperates with SALL4 to orchestrate reprogramming.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37208322","citation_count":28,"is_preprint":false},{"pmid":"19781444","id":"PMC_19781444","title":"Overexpression of the novel oncogene SALL4 and activation of the Wnt/beta-catenin pathway in myelodysplastic syndromes.","date":"2009","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/19781444","citation_count":28,"is_preprint":false},{"pmid":"32071327","id":"PMC_32071327","title":"Thalidomide Inhibits Human iPSC Mesendoderm Differentiation by Modulating CRBN-dependent Degradation of SALL4.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32071327","citation_count":28,"is_preprint":false},{"pmid":"22150312","id":"PMC_22150312","title":"The role of stem cell factor SALL4 in leukemogenesis.","date":"2011","source":"Critical reviews in oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/22150312","citation_count":27,"is_preprint":false},{"pmid":"36010677","id":"PMC_36010677","title":"SALL4: An Intriguing Therapeutic Target in Cancer Treatment.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/36010677","citation_count":27,"is_preprint":false},{"pmid":"34417458","id":"PMC_34417458","title":"Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34417458","citation_count":26,"is_preprint":false},{"pmid":"21258884","id":"PMC_21258884","title":"Immunoexpression of SALL4 in Wilms tumors and developing kidney.","date":"2011","source":"Pathology oncology research : POR","url":"https://pubmed.ncbi.nlm.nih.gov/21258884","citation_count":26,"is_preprint":false},{"pmid":"30127890","id":"PMC_30127890","title":"miR-16 targets SALL4 to repress the proliferation and migration of gastric cancer.","date":"2018","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/30127890","citation_count":25,"is_preprint":false},{"pmid":"27601921","id":"PMC_27601921","title":"Knockdown of Sall4 inhibits intrahepatic cholangiocarcinoma cell migration and invasion in ICC-9810 cells.","date":"2016","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/27601921","citation_count":24,"is_preprint":false},{"pmid":"26935744","id":"PMC_26935744","title":"Knockdown of SALL4 inhibits the proliferation and reverses the resistance of MCF-7/ADR cells to doxorubicin hydrochloride.","date":"2016","source":"BMC molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/26935744","citation_count":24,"is_preprint":false},{"pmid":"30603774","id":"PMC_30603774","title":"Whole-exome sequencing reveals SALL4 variants in premature ovarian insufficiency: an update on genotype-phenotype correlations.","date":"2019","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30603774","citation_count":24,"is_preprint":false},{"pmid":"24827994","id":"PMC_24827994","title":"Differential SALL4 immunoexpression in malignant rhabdoid tumours and epithelioid sarcomas.","date":"2014","source":"Histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/24827994","citation_count":23,"is_preprint":false},{"pmid":"32948804","id":"PMC_32948804","title":"An IMiD-induced SALL4 degron system for selective degradation of target proteins.","date":"2020","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/32948804","citation_count":23,"is_preprint":false},{"pmid":"18781635","id":"PMC_18781635","title":"Sall4 isoforms act during proximal-distal and anterior-posterior axis formation in the mouse embryo.","date":"2008","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/18781635","citation_count":23,"is_preprint":false},{"pmid":"26617716","id":"PMC_26617716","title":"Inhibition of SALL4 suppresses carcinogenesis of colorectal cancer via regulating Gli1 expression.","date":"2015","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26617716","citation_count":22,"is_preprint":false},{"pmid":"33644042","id":"PMC_33644042","title":"Up-Regulation of SALL4 Is Associated With Survival and Progression via Putative WNT Pathway in Gastric Cancer.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/33644042","citation_count":21,"is_preprint":false},{"pmid":"31009138","id":"PMC_31009138","title":"miR-188-5p emerges as an oncomiRNA to promote gastric cancer cell proliferation and migration via upregulation of SALL4.","date":"2019","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31009138","citation_count":21,"is_preprint":false},{"pmid":"23122807","id":"PMC_23122807","title":"Aberrant hypomethylation of SALL4 gene in patients with myelodysplastic syndrome.","date":"2012","source":"Leukemia research","url":"https://pubmed.ncbi.nlm.nih.gov/23122807","citation_count":21,"is_preprint":false},{"pmid":"22448662","id":"PMC_22448662","title":"Diagnostic utility of CD117, CD133, SALL4, OCT4, TCL1 and glypican-3 in malignant germ cell tumors of the ovary.","date":"2012","source":"The journal of obstetrics and gynaecology research","url":"https://pubmed.ncbi.nlm.nih.gov/22448662","citation_count":21,"is_preprint":false},{"pmid":"34732693","id":"PMC_34732693","title":"miR-497-5p/SALL4 axis promotes stemness phenotype of choriocarcinoma and forms a feedback loop with DNMT-mediated epigenetic regulation.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34732693","citation_count":20,"is_preprint":false},{"pmid":"27576349","id":"PMC_27576349","title":"SOX1 is correlated to stemness state regulator SALL4 through progression and invasiveness of esophageal squamous cell carcinoma.","date":"2016","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/27576349","citation_count":20,"is_preprint":false},{"pmid":"34593523","id":"PMC_34593523","title":"Targeting an Inducible SALL4-Mediated Cancer Vulnerability with Sequential Therapy.","date":"2021","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/34593523","citation_count":19,"is_preprint":false},{"pmid":"23201546","id":"PMC_23201546","title":"Aberrant hypomethylation of SALL4 gene is associated with intermediate and poor karyotypes in acute myeloid leukemia.","date":"2012","source":"Clinical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23201546","citation_count":19,"is_preprint":false},{"pmid":"34050851","id":"PMC_34050851","title":"Long noncoding HOXA11-AS knockdown suppresses the progression of non-small cell lung cancer by regulating miR-3619-5p/SALL4 axis.","date":"2021","source":"Journal of molecular histology","url":"https://pubmed.ncbi.nlm.nih.gov/34050851","citation_count":17,"is_preprint":false},{"pmid":"25174577","id":"PMC_25174577","title":"SALL4: engine of cell stemness.","date":"2014","source":"Current gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/25174577","citation_count":16,"is_preprint":false},{"pmid":"22555391","id":"PMC_22555391","title":"Role of SALL4 in hematopoiesis.","date":"2012","source":"Current opinion in hematology","url":"https://pubmed.ncbi.nlm.nih.gov/22555391","citation_count":16,"is_preprint":false},{"pmid":"37337914","id":"PMC_37337914","title":"The new advance of SALL4 in cancer: Function, regulation, and implication.","date":"2023","source":"Journal of clinical laboratory analysis","url":"https://pubmed.ncbi.nlm.nih.gov/37337914","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48755,"output_tokens":8970,"usd":0.140407},"stage2":{"model":"claude-opus-4-6","input_tokens":12847,"output_tokens":4046,"usd":0.248078},"total_usd":0.388485,"stage1_batch_id":"msgbatch_011rkcQdVV1RaFq9XhcG6df6","stage2_batch_id":"msgbatch_01RzgrJafdF4EWHhj5mNi6dh","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2006,\n      \"finding\": \"Sall4 directly binds the highly conserved distal enhancer region of the Pou5f1 (Oct4) gene and transcriptionally activates Oct4 expression in vivo and in vitro; knockdown of Sall4 in mouse zygotes reduced both Sall4 and Oct4 mRNAs and expanded Cdx2 expression into the inner cell mass, demonstrating that Sall4 is a transcriptional activator of Oct4 required for ES cell pluripotency.\",\n      \"method\": \"ChIP, luciferase reporter assay, siRNA microinjection into zygotes, in vitro transcription assay\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (ChIP, reporter assay, in vivo siRNA knockdown) in a single study with replicated findings\",\n      \"pmids\": [\"16980957\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Sall4 physically interacts with Nanog (confirmed by affinity purification/MS, Co-IP, and GST pulldown) and co-occupies Nanog and Sall4 enhancer regions in living ES cells; knockdown of either factor reduces the other's enhancer activity, indicating a positive autoregulatory loop.\",\n      \"method\": \"Affinity purification coupled to LC-MS/MS, Co-immunoprecipitation, GST pulldown, ChIP\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reciprocal Co-IP plus GST pulldown plus ChIP, multiple orthogonal methods\",\n      \"pmids\": [\"16840789\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"SALL4 promoter contains a consensus TCF/LEF-binding site; LEF1 and TCF4E directly activate the SALL4 promoter, and mutation of the TCF/LEF-binding site reduces promoter activation, demonstrating SALL4 is a direct transcriptional target of canonical Wnt signaling.\",\n      \"method\": \"Promoter cloning, luciferase reporter assay, site-directed mutagenesis of TCF/LEF binding site\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reporter assay with mutagenesis, single lab\",\n      \"pmids\": [\"16899215\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"In zebrafish, sall4 acts genetically downstream of tbx5 and is required for pectoral fin (forelimb) outgrowth, placing sall4 in the tbx5 pathway during limb development.\",\n      \"method\": \"Genetic epistasis in zebrafish (morpholino knockdown, overexpression)\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic epistasis in a vertebrate model organism with clear phenotypic readout\",\n      \"pmids\": [\"16501170\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Sall4 is cell-autonomously required for development of epiblast and primitive endoderm from the inner cell mass; Sall4-deficient blastocysts cannot give rise to embryonic or extraembryonic endoderm stem cell lines, whereas trophoblast lineage development is unaffected.\",\n      \"method\": \"Conditional knockout mice, blastocyst stem cell derivation assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with specific lineage phenotype readout, replicated in multiple derivation assays\",\n      \"pmids\": [\"17060609\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Genome-wide ChIP-on-chip mapping identified >3,200 Sall4 target genes in mouse ES cells; Sall4 forms a heteromeric protein complex with Oct4 and Nanog (confirmed by co-IP), and decreasing Sall4 reduces expression of Oct4, Sox2, c-Myc, and Klf4.\",\n      \"method\": \"ChIP-on-chip, Co-immunoprecipitation, RNAi knockdown with expression profiling\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide binding map combined with reciprocal Co-IP and functional knockdown, multiple orthogonal methods\",\n      \"pmids\": [\"19060217\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Sall4 regulates distinct gene sets in ES cells versus extraembryonic endoderm (XEN) cells; in ES cells Sall4 forms an autoregulatory network with Oct4, Sox2, and Nanog, while in XEN cells it regulates Gata4, Gata6, Sox7, and Sox17, demonstrating context-dependent transcriptional circuitry.\",\n      \"method\": \"Genome-wide ChIP-seq/ChIP-chip, siRNA knockdown, gene expression profiling in two distinct stem cell lines\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide binding plus functional knockdown in two cell types, strong evidence for distinct regulatory circuits\",\n      \"pmids\": [\"18804426\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Compound Sall1/Sall4 and Sall2/Sall4 mutant mice show significantly increased neural tube defects, and SALL1, SALL2, and SALL4 proteins all co-localize in the nucleus in vitro, suggesting redundant nuclear functions in neurulation.\",\n      \"method\": \"Compound knockout mouse genetics, nuclear co-localization (immunofluorescence)\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with clear neural tube phenotype, supported by localization data\",\n      \"pmids\": [\"18818376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"SALL4 associates with the Mi-2/NuRD (Nucleosome Remodeling and Deacetylase) complex, identified by tandem mass spectrometry from SALL4 immunocomplexes; this complex has HDAC activity. SALL4 binds the promoter regions of PTEN and SALL1 (by ChIP) and represses their transcription through the NuRD complex; in SALL4 transgenic mice, decreased PTEN and SALL1 expression is associated with myeloid leukemia and cystic kidneys, respectively.\",\n      \"method\": \"Co-immunoprecipitation, tandem mass spectrometry, HDAC activity assay, ChIP, qRT-PCR, transgenic mouse model\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — MS identification of complex, ChIP confirming binding, functional transgenic readout, multiple orthogonal methods\",\n      \"pmids\": [\"19440552\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Sall4 exists as two isoforms (Sall4a and Sall4b) that form homodimers and heterodimers with each other and each interacts with Nanog; Sall4b (but not Sall4a) preferentially binds highly expressed loci and can alone maintain the pluripotent state, though incompletely, while Sall4a and Sall4b have overlapping but distinct genome-wide binding sites differing in epigenetic marks.\",\n      \"method\": \"Genome-wide location analysis (ChIP-seq), Co-immunoprecipitation, isoform-specific ES cell rescue experiments\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide ChIP plus Co-IP plus isoform-specific rescue, multiple orthogonal methods\",\n      \"pmids\": [\"20837710\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SALL4 and OCT4 form a bidirectional transcriptional feedback loop: SALL4 activates OCT4 expression and OCT4 activates SALL4, while SALL4 also strongly self-represses its own promoter and represses promoters of SALL1 and SALL3, antagonizing OCT4-mediated activation of those genes.\",\n      \"method\": \"Luciferase reporter assay, ChIP, qRT-PCR, co-transfection\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reporter assays plus ChIP, single lab\",\n      \"pmids\": [\"20505821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In differentiating spermatogonial progenitor cells (SPCs), Sall4 physically interacts with Plzf (by Co-IP), sequesters Plzf to non-cognate chromatin domains to de-repress Kit expression (a Plzf target required for differentiation), while Plzf reciprocally antagonizes Sall4 by displacing it from cognate chromatin to induce Sall1 expression.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, genetic loss-of-function (conditional knockout mice), gene expression analysis\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP plus ChIP plus genetic epistasis, multiple orthogonal methods\",\n      \"pmids\": [\"22385656\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Sall4 directly interacts with Sox2 and Oct-3/4 (confirmed by Co-IP), and co-occupies Oct-Sox composite elements in mouse ES cells (by ChIP); Sall4 overexpression increases reporter activity driven by Oct-Sox elements from Pou5f1 and Nanog promoters.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, luciferase reporter assay, microarray\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, ChIP, and functional reporter assays, multiple orthogonal methods\",\n      \"pmids\": [\"23269686\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SALL4B is modified by sumoylation at lysine residues 156, 316, 374, and 401; sumoylation is independent of ubiquitination, stabilizes the protein, affects its subcellular localization (SUMO-deficient SALL4B enriched in chromatin fraction), and is required for full transcriptional activation/repression activity and rescue of OCT4 and SOX2 expression.\",\n      \"method\": \"Site-directed mutagenesis, mass spectrometry, reporter assays, RNAi rescue experiments, subcellular fractionation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis of modification sites combined with functional rescue and subcellular fractionation, multiple methods\",\n      \"pmids\": [\"23012367\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SALL4 binds the promoter of the HOXA9 gene in leukemic cells (by ChIP), interacts with MLL (by Co-IP), and co-occupies the HOXA9 promoter with MLL, leading to enrichment of activating histone marks (H3K4me3); downregulation of HoxA9 in SALL4B leukemic cells reduces replating capacity and delays AML development.\",\n      \"method\": \"ChIP, Co-immunoprecipitation, shRNA knockdown, bone marrow transplantation mouse model, histone modification analysis\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus Co-IP plus in vivo leukemia model, multiple orthogonal methods\",\n      \"pmids\": [\"24051379\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"A peptide that competes with SALL4 for binding to the HDAC (NuRD) complex reverses SALL4-mediated PTEN repression, leading to death of SALL4-expressing leukemic cells in vitro and in vivo in xenograft models; this effect is rescued by a PTEN inhibitor, confirming PTEN as the relevant target.\",\n      \"method\": \"Peptide competition assay, HDAC activity assay, ChIP, xenograft mouse model, RNAi comparison\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic peptide competition validated in vitro and in vivo with rescue experiment\",\n      \"pmids\": [\"23287862\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In hepatocellular carcinoma, blocking SALL4-corepressor (NuRD/HDAC) interactions releases suppression of PTEN, inhibiting tumor formation in xenograft models, establishing that SALL4 drives HCC tumorigenicity at least in part by epigenetic silencing of PTEN.\",\n      \"method\": \"Loss-of-function studies (RNAi), peptide blockade of SALL4-corepressor interaction, in vivo xenograft assay\",\n      \"journal\": \"The New England journal of medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional loss-of-function plus mechanistic peptide intervention plus in vivo xenograft readout\",\n      \"pmids\": [\"23758232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"An Oct4-Sall4-Nanog network governs pre-implantation mouse embryo development; morpholino-mediated knockdown of each factor followed by transcriptome analysis defined their regulons, including a set of metabolism/transport genes regulated in embryos but not ES cells. DNMT3b, controlled by these factors and miR-290-295, buffers embryos against gene expression noise.\",\n      \"method\": \"Morpholino knockdown in embryos, single-embryo and single-blastomere transcriptome analysis, genetic epistasis\",\n      \"journal\": \"Molecular systems biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic knockdown with transcriptome readout in embryos, single lab\",\n      \"pmids\": [\"23295861\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Sall4 is required for primordial germ cell (PGC) specification; conditional inactivation of Sall4 during PGC specification leads to apoptosis and failure of PGC translocation from mesoderm to endoderm, with derepression of somatic program genes Hoxa1 and Hoxb1 while stem cell program activation is intact. Sall4 binds these somatic gene loci (ChIP) and likely recruits a histone deacetylase repressor complex with Prdm1.\",\n      \"method\": \"Conditional knockout mice, ChIP, gene expression analysis, cell fate tracking\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with specific PGC phenotype plus ChIP mechanistic data\",\n      \"pmids\": [\"25263278\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Sall4 is required for activating ATM-dependent DNA double-strand break (DSB) responses in mouse ES cells; Sall4 rapidly localizes to DSB sites, interacts with Rad50 (Co-IP), stabilizes the Mre11-Rad50-Nbs1 (MRN) complex for ATM recruitment and activation, and interacts with Baf60a (SWI/SNF complex member) which recruits Sall4 to DSB sites.\",\n      \"method\": \"Live-cell imaging (localization to DSB sites), Co-immunoprecipitation, siRNA knockdown, ATM activation assays, FRAP\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct visualization of recruitment, reciprocal Co-IP of MRN complex stabilization, functional ATM assay, multiple methods\",\n      \"pmids\": [\"25733712\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Sall4 is an enhancer-binding protein that prevents precocious neural gene expression in ES cells; although a fraction of Sall4 protein physically associates with the NuRD complex, Sall4 neither recruits NuRD to chromatin nor regulates transcription via NuRD — free Sall4 protein regulates transcription independently of NuRD.\",\n      \"method\": \"Sall4 knockout ES cells, ChIP-seq, proteomics (mass spectrometry), NuRD recruitment assays, gene expression profiling\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — genome-wide ChIP-seq combined with KO ES cells and proteomic analysis, strong mechanistic dissection\",\n      \"pmids\": [\"27471257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In undifferentiated spermatogonia, SALL4 and PLZF bind 1295 shared gene targets; SALL4 preferentially binds intronic sites (including DMRT1 differentiation factor motifs) while PLZF binds promoters; knockdown of either factor suppresses mRNA levels of both unique and shared target genes involved in SSC self-renewal and differentiation.\",\n      \"method\": \"ChIP-seq in mouse THY1+ spermatogonia, motif analysis, shRNA knockdown with expression profiling\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide ChIP-seq plus functional knockdown in primary spermatogonia\",\n      \"pmids\": [\"27068105\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"SALL4 promotes glycolysis and open chromatin by recruiting ubiquitin E3 ligase CUL4B to heterochromatin protein 1α (HP1α), destabilizing HP1α; loss of SALL4 reduces Glut1 expression and inhibits glycolysis; restoring Glut1 expression rescues impaired DNA damage response in SALL4-deficient cancer cells, establishing a SALL4-HP1α-Glut1 axis.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, ChIP, siRNA knockdown, Glut1 rescue experiments\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP and rescue experiments, single lab\",\n      \"pmids\": [\"28759035\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"In undifferentiated spermatogonia, SALL4 associates with the NuRD co-repressor and represses tumor suppressor genes Foxl1 and Dusp4; inducible SALL4 knockout leads to long-term functional decline of undifferentiated spermatogonia, and aberrant Foxl1 activation inhibits cell growth and survival while DUSP4 suppresses self-renewal pathways.\",\n      \"method\": \"Inducible knockout mouse models, Co-immunoprecipitation (NuRD), gene expression analysis, functional spermatogonial assays\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — inducible KO with functional readout plus mechanistic NuRD Co-IP, multiple methods\",\n      \"pmids\": [\"28867346\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"SALL4 is required for MLL-AF9-induced leukemic transformation; loss of SALL4 induces apoptosis and G1 arrest in MLL-AF9 cells. SALL4 physically interacts with DOT1L and LSD1/KDM1A (Co-IP) and co-binds MLL-AF9 target gene promoters, affecting H3K79me2/3 and H3K4me3 histone marks to regulate their transcription.\",\n      \"method\": \"Tamoxifen-inducible Cre-mediated knockout, retroviral transduction/transplantation, ChIP-seq, Co-immunoprecipitation, histone modification analysis\",\n      \"journal\": \"Journal of hematology & oncology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — inducible KO in mouse leukemia model plus Co-IP of epigenetic factors plus ChIP-seq\",\n      \"pmids\": [\"28974232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Crystal structure of SALL4(1–12) N-terminal peptide complexed with RBBp4 (NuRD chaperone subunit) at 2.7 Å resolution was determined; systematic truncation and amino acid substitution defined an FFW peptide with 23 nM affinity that antagonizes SALL4-NuRD interaction; disrupting this interaction converts SALL4 from dual repressor-activator to singular activator mode, upregulating PTEN and inhibiting xenograft tumor growth by 85%.\",\n      \"method\": \"Crystal structure determination, peptide design with mutagenesis, surface plasmon resonance, transcriptome analysis, xenograft mouse model\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure plus mutagenesis plus in vitro affinity measurement plus in vivo validation, single highly rigorous study\",\n      \"pmids\": [\"29976840\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SALL4 binds the promoter of miR-146a-5p and directly controls its expression in HCC exosomes; this SALL4/miR-146a-5p axis drives M2 macrophage polarization and T cell exhaustion.\",\n      \"method\": \"ChIP assay (SALL4 binding to miR-146a-5p promoter), luciferase reporter, siRNA knockdown, in vivo DEN/CCL4 HCC mouse model\",\n      \"journal\": \"Oncoimmunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus reporter assay plus in vivo model, single lab\",\n      \"pmids\": [\"31143524\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SALL4 binds approximately 50% of mitochondrial genes by ChIP-seq and activates their transcription; SALL4-high cancer cells exhibit increased oxidative phosphorylation, oxygen consumption rate, and mitochondrial membrane potential compared to SALL4-knockdown cells, identifying SALL4 as a transcriptional activator of oxidative phosphorylation genes.\",\n      \"method\": \"ChIP-seq, RNA-seq, oxygen consumption rate measurement, mitochondrial membrane potential assay, xenograft models\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide ChIP-seq plus functional metabolic assays plus in vivo validation, strong mechanistic evidence\",\n      \"pmids\": [\"31446059\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Sall4 promotes WNT/β-catenin signaling to maintain neuromesodermal progenitors (NMPs) and regulate their differentiation balance toward neural versus mesodermal fates during body elongation; RNA-seq and ChIP-seq in post-gastrulation embryos confirmed Sall4 directly regulates mesodermal and neural developmental genes.\",\n      \"method\": \"Conditional knockout (TCre), RNA-seq, ChIP-seq, genetic interaction with WNT pathway\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with defined NMP phenotype plus genome-wide binding data\",\n      \"pmids\": [\"31235634\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SALL4 directly binds and transcriptionally activates CTNNB1 (β-catenin) promoter (confirmed by ChIP and dual-luciferase assay), activating Wnt/β-catenin signaling and increasing c-Myc and cyclin D1 in cervical cancer cells.\",\n      \"method\": \"ChIP assay, dual-luciferase reporter assay, Western blot, TOP/FOP-Flash Wnt reporter\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus reporter assay confirming direct promoter binding, single lab\",\n      \"pmids\": [\"31336010\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Thalidomide and IMiD analogs (lenalidomide, pomalidomide) induce SALL4 degradation through the CRBN-containing CRL4 E3 ubiquitin ligase complex; CRBN V388I or SALL4 G416A mutations block IMiD-induced SALL4 degradation and protect hiPSC mesendoderm differentiation from thalidomide, establishing CRBN-dependent SALL4 degradation as the mechanism of teratogenicity.\",\n      \"method\": \"hiPSC differentiation assays, CRBN and SALL4 point-mutant knock-in cells, proteasome inhibitor experiments, flow cytometry\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis of both CRBN and SALL4 with functional rescue, mechanistic demonstration of ubiquitin-mediated degradation\",\n      \"pmids\": [\"32071327\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SALL4 contains an AT-rich DNA-binding zinc-finger cluster that is essential for genome occupancy; mutation of this AT-binding domain drastically reduces SALL4 chromatin binding, causes premature upregulation of AT-rich neural genes proportional to AT content, and mimics Sall4 null defects including precocious ESC differentiation and embryonic lethality in mice.\",\n      \"method\": \"Zinc-finger mutagenesis, ChIP-seq, RNA-seq, mouse knock-in genetics\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structure-function mutagenesis combined with genome-wide ChIP-seq and in vivo mouse model, highly rigorous single study\",\n      \"pmids\": [\"33406384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SALL4 negatively regulates melanoma cell invasiveness through interaction with HDAC2; SALL4 and HDAC2 co-bind a set of invasiveness genes, and SALL4 loss promotes an invasive phenotype; HDAC inhibition phenocopies SALL4 loss, while inhibition of histone acetylation partially reverts the invasiveness induced by SALL4 knockdown.\",\n      \"method\": \"Co-immunoprecipitation (SALL4-HDAC2), ChIP, transcriptional profiling, mouse melanoma model (Tyr::NrasQ61K;Cdkn2a-/-), in vitro invasion assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP plus ChIP plus in vivo melanoma model, multiple orthogonal methods\",\n      \"pmids\": [\"34417458\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"The NuRD complex participates in chromatin closing during early somatic reprogramming; Sall4 uniquely recruits endogenous NuRD components among the reprogramming factors, and disrupting the N-terminal NuRD-interacting motif of Sall4 (by mutation or deletion) abolishes reprogramming ability; grafting this motif onto Jdp2 partially rescues reprogramming, demonstrating that Sall4-NuRD interaction is functionally essential for closing open chromatin.\",\n      \"method\": \"Co-immunoprecipitation, N-terminal motif mutagenesis/deletion, ATAC-seq (chromatin accessibility dynamics), iPSC reprogramming efficiency assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis plus domain-swap rescue plus genome-wide ATAC-seq, multiple rigorous methods\",\n      \"pmids\": [\"37208322\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"SALL4 binds the promoter of ABCA3 (confirmed by ChIP and EMSA) and directly activates ABCA3 expression, while regulating ABCG2 indirectly; SALL4 expression is enriched in drug-resistant side population (SP) cancer cells and its knockdown reduces SP cell frequency, linking SALL4 to drug resistance via ABC transporter regulation.\",\n      \"method\": \"ChIP, EMSA, qRT-PCR, siRNA knockdown, SP cell sorting\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus EMSA confirming direct promoter binding, functional knockdown, single lab\",\n      \"pmids\": [\"21526180\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"SALL4 directly binds the c-Myc promoter (confirmed by ChIP) and upregulates c-Myc expression; c-Myc depletion abolishes SALL4-induced EMT (downregulation of E-cadherin, upregulation of N-cadherin) and drug resistance (via ABCB1) in endometrial cancer cells.\",\n      \"method\": \"ChIP assay, siRNA knockdown, Western blot, invasion assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus functional rescue experiment, single lab\",\n      \"pmids\": [\"26407074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"SALL4 directly binds the CD44 promoter (confirmed by ChIP and luciferase assay) and transcriptionally activates CD44; CD44 overexpression rescues SALL4 knockdown-mediated inhibition of gastric cancer cell proliferation and invasion, establishing CD44 as a direct SALL4 target.\",\n      \"method\": \"ChIP, luciferase reporter assay, shRNA knockdown with rescue overexpression, in vivo xenograft\",\n      \"journal\": \"Oncogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus reporter plus rescue experiment, single lab\",\n      \"pmids\": [\"27819668\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SALL4 directly activates TGF-β1 transcription by binding its promoter (confirmed by ChIP and luciferase assay); TGF-β1 knockdown reverses SALL4-mediated promotion of gastric cancer motility and invasion, placing SALL4 upstream of TGF-β/SMAD-driven EMT.\",\n      \"method\": \"ChIP, luciferase reporter assay, microarray for target identification, invasion assays, peritoneal metastasis model\",\n      \"journal\": \"Cancer management and research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus reporter assay plus functional rescue, single lab\",\n      \"pmids\": [\"30349378\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SALL4 is a zinc-finger transcription factor that maintains pluripotency and stem cell identity by directly activating key target genes (Oct4/Pou5f1, Nanog, HOXA9, CD44, TGF-β1, CTNNB1, oxidative phosphorylation genes) through binding to their enhancers/promoters, and repressing tumor suppressors (PTEN, SALL1, Foxl1, Dusp4) and neural differentiation genes through recruitment of the NuRD/HDAC co-repressor complex via its N-terminal motif; it physically interacts with Oct4, Sox2, Nanog, MLL, PLZF, Rad50, HDAC2, and CUL4B, responds to Wnt/TCF-LEF signaling (which directly activates its promoter), is post-translationally regulated by sumoylation (stabilizing the protein and modulating its transcriptional activity) and by CRBN-dependent ubiquitin-mediated proteasomal degradation induced by thalidomide/IMiDs, and its AT-rich DNA-binding zinc-finger cluster is essential for chromatin occupancy and prevention of precocious neural differentiation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SALL4 is a zinc-finger transcription factor that serves as a master regulator of pluripotency, stem cell self-renewal, and lineage specification across embryonic, germline, and hematopoietic compartments. It maintains the pluripotent state by physically interacting with Oct4, Sox2, and Nanog to co-occupy and activate enhancers of core pluripotency genes (Pou5f1, Nanog), while repressing differentiation and tumor-suppressor genes (PTEN, SALL1, Foxl1) through recruitment of the NuRD/HDAC co-repressor complex via a structurally defined N-terminal RBBp4-binding motif; this dual activator–repressor function is essential for somatic reprogramming and prevention of precocious neural differentiation [PMID:16980957, PMID:19440552, PMID:27471257, PMID:37208322, PMID:29976840]. Its AT-rich DNA-binding zinc-finger cluster is required for genome-wide chromatin occupancy, and mutation of this domain phenocopies Sall4 nulls including embryonic lethality [PMID:33406384]. SALL4 is post-translationally regulated by sumoylation, which stabilizes the protein and modulates transcriptional output, and by CRBN-dependent ubiquitin-mediated proteasomal degradation induced by thalidomide/IMiDs — establishing SALL4 degradation as the mechanism underlying thalidomide teratogenicity [PMID:23012367, PMID:32071327].\",\n  \"teleology\": [\n    {\n      \"year\": 2006,\n      \"claim\": \"Establishing SALL4 as a direct transcriptional activator of the core pluripotency gene Oct4 answered how the inner cell mass maintains Oct4 expression and resolved that SALL4 occupies the Pou5f1 distal enhancer to prevent trophoblast fate.\",\n      \"evidence\": \"ChIP, luciferase reporter, siRNA knockdown in mouse zygotes\",\n      \"pmids\": [\"16980957\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SALL4 activates Oct4 independently or requires cofactors was unresolved\", \"Mechanism of transcriptional activation (chromatin remodeling vs. polymerase recruitment) unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrating that SALL4 physically interacts with Nanog and that the two factors co-occupy each other's enhancers revealed a positive autoregulatory loop that stabilizes the pluripotency network, while identification of SALL4 as a Wnt/TCF-LEF target gene placed it downstream of a major developmental signaling pathway.\",\n      \"evidence\": \"Affinity purification/MS, Co-IP, GST pulldown, ChIP (SALL4-Nanog); luciferase reporter with TCF/LEF site mutagenesis (Wnt regulation)\",\n      \"pmids\": [\"16840789\", \"16899215\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Wnt-mediated SALL4 induction is the primary mechanism activating SALL4 in vivo remained untested\", \"Stoichiometry of the SALL4-Nanog complex unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Genome-wide binding maps and genetic loss-of-function showed SALL4 occupies thousands of targets and is essential for epiblast and primitive endoderm but not trophoblast, establishing context-dependent regulatory circuits distinct between ES and extraembryonic endoderm cells.\",\n      \"evidence\": \"ChIP-on-chip/ChIP-seq in ES and XEN cells, conditional knockout mice, stem cell derivation assays\",\n      \"pmids\": [\"17060609\", \"19060217\", \"18804426\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How SALL4 switches between activating and repressive modes in different lineages was unknown\", \"Whether SALL4 isoforms contribute to lineage-specific programs was unresolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identification of SALL4 as a recruiter of the NuRD/HDAC co-repressor complex that silences PTEN and SALL1 explained how SALL4 functions as a transcriptional repressor and linked this mechanism to myeloid leukemia and cystic kidney phenotypes.\",\n      \"evidence\": \"Co-IP/tandem mass spectrometry of SALL4 immunocomplexes, ChIP on PTEN and SALL1 promoters, HDAC activity assay, transgenic mouse model\",\n      \"pmids\": [\"19440552\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NuRD is required for all SALL4-mediated repression or only a subset of targets was unknown\", \"Structural basis of the SALL4-NuRD interaction was unresolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Discovery that Sall4a and Sall4b isoforms form homo- and heterodimers, occupy distinct but overlapping genomic sites, and differ in capacity to maintain pluripotency (Sall4b sufficient, Sall4a insufficient alone) revealed isoform-specific division of labor.\",\n      \"evidence\": \"Isoform-specific ChIP-seq, Co-IP, ES cell rescue experiments\",\n      \"pmids\": [\"20837710\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for differential DNA binding of isoforms unknown\", \"How isoform ratio is regulated during differentiation was unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showing that SALL4 and PLZF physically interact and mutually redistribute each other on chromatin in spermatogonia established a reciprocal chromatin-sequestration mechanism controlling the self-renewal-to-differentiation switch in male germline stem cells.\",\n      \"evidence\": \"Co-IP, ChIP, conditional knockout mice, gene expression analysis in spermatogonial progenitor cells\",\n      \"pmids\": [\"22385656\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this sequestration mechanism operates in other stem cell compartments was unknown\", \"Genome-wide redistribution of SALL4 by PLZF was not mapped\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identification of sumoylation sites on SALL4B and demonstration that sumoylation stabilizes the protein, modulates its chromatin association, and is required for full transcriptional activity established the first post-translational regulatory mechanism for SALL4.\",\n      \"evidence\": \"Site-directed mutagenesis of four lysines, mass spectrometry, subcellular fractionation, reporter assays, RNAi rescue in ES cells\",\n      \"pmids\": [\"23012367\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the SUMO E3 ligase for SALL4 was unknown\", \"Whether sumoylation is regulated during differentiation was untested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstrating that SALL4 cooperates with MLL at the HOXA9 promoter via physical interaction and co-occupancy with activating H3K4me3 marks explained how SALL4 drives leukemogenic gene expression programs, while peptide disruption of the SALL4-NuRD interface validated PTEN de-repression as a therapeutic vulnerability in SALL4-expressing cancers.\",\n      \"evidence\": \"ChIP, Co-IP, bone marrow transplantation leukemia model (SALL4-MLL); peptide competition, xenograft models, PTEN inhibitor rescue (SALL4-NuRD-PTEN)\",\n      \"pmids\": [\"24051379\", \"23287862\", \"23758232\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SALL4 cooperates with MLL independent of NuRD was unresolved\", \"In vivo pharmacokinetics of NuRD-disrupting peptides were not established\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Revealing that SALL4 rapidly localizes to DNA double-strand breaks, stabilizes the MRN complex through direct Rad50 interaction, and is required for ATM activation uncovered an unexpected non-transcriptional role for SALL4 in the DNA damage response.\",\n      \"evidence\": \"Live-cell imaging, FRAP, Co-IP with Rad50 and Baf60a, ATM phosphorylation assays in ES cells\",\n      \"pmids\": [\"25733712\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SALL4's DSB role is specific to ES cells or general was unknown\", \"Structural basis of SALL4-Rad50 interaction unresolved\", \"Whether SALL4 DNA damage function is independent of its transcriptional role was unclear\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Genome-wide analysis in Sall4 knockout ES cells showed SALL4 acts primarily at enhancers to prevent precocious neural gene activation, and critically, that although SALL4 physically associates with NuRD, it does not recruit NuRD to chromatin — challenging the prevailing model of SALL4 as a NuRD-dependent repressor.\",\n      \"evidence\": \"ChIP-seq and proteomics in Sall4 KO ES cells, NuRD recruitment assays\",\n      \"pmids\": [\"27471257\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How to reconcile this with functional NuRD-dependence shown in cancer and spermatogonia was unclear\", \"Identity of the actual repressive mechanism at neural enhancers was unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Solving the crystal structure of the SALL4 N-terminal peptide bound to RBBp4 and engineering a high-affinity competitive peptide (23 nM) that converts SALL4 from repressor to activator provided the structural basis for the NuRD interaction and a pharmacological strategy to de-repress PTEN in tumors.\",\n      \"evidence\": \"X-ray crystallography at 2.7 Å, surface plasmon resonance, systematic peptide truncation/mutagenesis, xenograft tumor model\",\n      \"pmids\": [\"29976840\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether small molecules can mimic the peptide antagonist was unknown\", \"Whether other NuRD-binding transcription factors share this structural interface was untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrating that thalidomide/IMiDs induce SALL4 degradation via the CRBN-CRL4 E3 ubiquitin ligase, and that point mutations in either CRBN or SALL4 block degradation and rescue mesendoderm differentiation, established CRBN-dependent SALL4 destruction as the molecular mechanism of thalidomide teratogenicity.\",\n      \"evidence\": \"CRBN V388I and SALL4 G416A knock-in hiPSCs, proteasome inhibitor treatment, mesendoderm differentiation assays\",\n      \"pmids\": [\"32071327\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the SALL4-thalidomide-CRBN ternary complex was not determined\", \"Whether SALL4 degradation alone fully accounts for all limb teratogenicity phenotypes was uncertain\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Structure-function analysis of the SALL4 AT-rich DNA-binding zinc-finger cluster showed it is essential for genome-wide chromatin occupancy and that its loss causes premature derepression of AT-rich neural genes, establishing the DNA-binding mechanism underlying SALL4's anti-differentiation function.\",\n      \"evidence\": \"Zinc-finger mutagenesis, ChIP-seq, RNA-seq, mouse knock-in genetics\",\n      \"pmids\": [\"33406384\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether AT-richness fully explains target selectivity or additional sequence features contribute was unknown\", \"How AT-binding cooperates with cofactor interactions was unresolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Showing that SALL4's N-terminal NuRD-interacting motif is essential for chromatin closing during somatic reprogramming, and that grafting this motif onto a non-reprogramming factor partially rescues iPSC generation, reconciled the ES cell finding (NuRD-independent) with a functional NuRD requirement in the reprogramming context.\",\n      \"evidence\": \"N-terminal motif mutagenesis/deletion, domain-swap onto Jdp2, ATAC-seq, iPSC reprogramming assays\",\n      \"pmids\": [\"37208322\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NuRD recruitment is required transiently or throughout reprogramming was unclear\", \"Which specific NuRD subunits are essential for this chromatin-closing function was not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: how SALL4's NuRD-dependent and NuRD-independent transcriptional activities are partitioned across cell types; the structural basis of the SALL4-CRBN-thalidomide ternary complex; and whether SALL4's DNA damage response function is mechanistically separable from its transcriptional role.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Full structural characterization of SALL4-CRBN-IMiD ternary complex lacking\", \"Context-dependent rules governing NuRD-dependent vs. NuRD-independent repression undefined\", \"Whether SALL4 DSB function operates outside stem cells not tested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 5, 6, 9, 20, 31]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 5, 6, 8, 10, 14, 20, 27, 31]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [11, 22]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [7, 13, 20, 31]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [19, 31]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0074160\", \"supporting_discovery_ids\": [0, 5, 6, 10, 14, 20, 27]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [3, 4, 18, 28]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [8, 20, 25, 33]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [19]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [14, 24, 16]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 28, 29, 30]}\n    ],\n    \"complexes\": [\n      \"NuRD/Mi-2 complex\",\n      \"Oct4-Sox2-Nanog-Sall4 pluripotency complex\"\n    ],\n    \"partners\": [\n      \"POU5F1\",\n      \"NANOG\",\n      \"SOX2\",\n      \"RBBP4\",\n      \"PLZF\",\n      \"RAD50\",\n      \"MLL\",\n      \"HDAC2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}